Dermatology and Mohs Surgery Institute Revenue and Competitors
Estimated Revenue & Valuation
- Dermatology and Mohs Surgery Institute's estimated annual revenue is currently $14.6M per year.
- Dermatology and Mohs Surgery Institute's estimated revenue per employee is $243,000
Employee Data
- Dermatology and Mohs Surgery Institute has 60 Employees.
- Dermatology and Mohs Surgery Institute grew their employee count by 9% last year.
Dermatology and Mohs Surgery Institute's People
Name | Title | Email/Phone |
---|
Dermatology and Mohs Surgery Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.3M | 59 | -2% | N/A | N/A |
#2 | $35.4M | 131 | 7% | N/A | N/A |
#3 | $24.3M | 90 | 18% | N/A | N/A |
#4 | $0.3M | 2 | -85% | N/A | N/A |
#5 | $33.8M | 125 | 7% | N/A | N/A |
#6 | $7.6M | 35 | 0% | N/A | N/A |
#7 | $125.6M | 372 | -1% | N/A | N/A |
#8 | $5.1M | 27 | -7% | N/A | N/A |
#9 | $7.8M | 36 | 9% | N/A | N/A |
#10 | $8.9M | 41 | 17% | N/A | N/A |
What Is Dermatology and Mohs Surgery Institute?
Mohs Surgery, Medical, and Cosmetic Dermatology. Our board certified dermatologists have the experience and expertise to treat all of your general and aesthetic skin care needs. Our providers are committed to delivering excellent and individualized skin care for our patients. Our medical expertise spans the spectrum of skin disorders ranging from acne, psoriasis, eczema, and warts to cutting edge skin cancer screening and treatment. We offer a comprehensive suite of cosmetic therapies incuding Botox, injectable volume restoration (using fillers such as Juvederm, Restylane, and Perlane), chemical peels, sclerotherapy, and laser treatments.
keywords:N/AN/A
Total Funding
60
Number of Employees
$14.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 60 | -8% | N/A |
#2 | $11.7M | 62 | 5% | N/A |
#3 | $7.6M | 62 | -2% | $1.3M |
#4 | $14.1M | 62 | N/A | N/A |
#5 | N/A | 62 | 9% | N/A |